Navigation Links
2 Cardiovascular Proteins Tied to Severity of Alzheimer's
Date:12/22/2008

Their interaction cuts blood flow to brain, limiting its ability to shed plaques

MONDAY, Dec. 22 (HealthDay News) -- U.S. researchers have spotted two proteins that deliver a double hit to the brain function of Alzheimer's disease patients.

The proteins -- SRF (serum response factor) and myocardin -- lessen blood flow in the brain and reduce the rate at which the brain is able to remove amyloid beta, the protein that accumulates in damaging quantities in the brains of Alzheimer's patients, say a team from the University of Rochester.

The findings provide firm evidence directly linking two processes believed to play a role in Alzheimer's: a reduction in blood flow and a buildup of toxic amyloid beta. The interaction between the two proteins could prove an effective target for treatment.

The researchers said they were surprised to discover that two proteins known for their role in the cardiovascular system were major factors in the development of Alzheimer's disease.

The study was published online Dec. 21 in the journal Nature Cell Biology.

"This is quite unexpected," senior author and Rochester neuroscientist Dr. Berislav Zlokovic, said in a journal news release. "On the other hand, both of these processes are mediated by the smooth muscle cells along blood vessel walls, and we know that those are seriously compromised in patients with Alzheimer's disease, so perhaps we shouldn't be completely surprised."

More information

The U.S. National Institute on Aging has more about Alzheimer's disease.



-- Robert Preidt



SOURCE: University of Rochester, news release, Dec. 21, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Page: 1

Related medicine news :

1. Two cardiovascular proteins pose a double whammy in Alzheimers
2. The Endovascular Forum, Inc. and the Society for Cardiovascular Angiography and Interventions Partner to Extend the Influence of Electronic Medical Care Innovation to Cardiovascular Medicine Through www.EndoVascular.Org, a Global, Multi-disciplinary Care
3. Terumo Corporation Announces Settlement of all Patent Litigation with Maquet Cardiovascular
4. Foundation Radiology Group Adds World Class Cardiovascular Imaging Expert, Dr. Sanj Katyal, to Staff
5. Presence of gum disease may help dentists and physicians identify risk for cardiovascular disease
6. Hospitals to Lose an Average $10,000 to $20,000 per Case on Common Cardiovascular Procedures Under Medicares Value-based Purchasing Program
7. New study: A Common Class of GI Medications Reduce Protection Against Heart Attack in Patients Taking Widely Prescribed Cardiovascular Drug
8. Correspondent Honored for Reporting on Cardiovascular Disease
9. The Results From a Clinical Trial Led by the Montreal Heart Institute Demonstrate That Drug Reduces Inflammation in Patients With Serious Cardiovascular Disease
10. Vitamins E and C supplements not effective for prevention of cardiovascular disease in men
11. Researchers discover new risk factor for cardiovascular disease, and a way to control it
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
2 Cardiovascular Proteins Tied to Severity of Alzheimer's 
(Date:9/29/2014)... CuteBobble.com, an experienced supplier that provides ... new collection of custom bobbleheads for Christmas. ... these quality items. Moreover, all the company’s old and ... code: 10USDOFF). The promotion will last until December 15, ... new designs of custom bobbleheads . Now, our ...
(Date:9/29/2014)... (PRWEB) September 30, 2014 Shoulder pain is ... those with persistent shoulder pain generates nearly ¾ of the ... 20-33% of all adults will experience shoulder pain, and of ... has also been reported that 1 in 4 people with ... less than a year. , “This is a real problem, ...
(Date:9/29/2014)... FL (PRWEB) September 30, 2014 Only ... than $20 can improve well-being, says Sublime Beauty®.The secret ... in Skin Brushes and have introduced thousands to this ... , Heshelow was interviewed recently on the eHealth ... to learn more . , "We have just released ...
(Date:9/29/2014)... (PRWEB) September 30, 2014 Foundations Recovery ... to announce the start of its 40th national conference ... Greenwald as a featured keynote speaker at the Moments ... experts specializing in the fields of addiction and mental ... Palm Beach, Fla., September 29 – October 2, 2014, ...
(Date:9/29/2014)... Atlanta, GA (PRWEB) September 30, 2014 In ... Whiter Image Dental has recently implemented some principles from the ... company as a whole. Whiter Image CEO Brad Stevens ... the “Most eye-opening seminar [he had] ever been to.” The ... business leaders produce great results by tapping into the desire ...
Breaking Medicine News(10 mins):Health News:Customers Can Get $10 Discount Coupons For Christmas When Ordering Custom Bobbleheads At CuteBobble.com 2Health News:KORT Physical Therapist Shines a Light on Shoulder Pain and Latest Treatments 2Health News:7 Easy Steps to Skin Brushing Guide Available from Sublime Beauty®; Body Brushing Details Revealed in eHealth Radio Network Interview 2Health News:Glenn Greenwald Addresses Drug Decriminalization at Foundations Recovery Network’s 40th National Conference 2Health News:Glenn Greenwald Addresses Drug Decriminalization at Foundations Recovery Network’s 40th National Conference 3Health News:Whiter Image Launches Four Disciplines of Execution Initiative into Corporate Strategy 2
... 2009 The world,s top lung cancer specialists, medical ... Francisco, CA for the 13th World Conference on Lung ... Study of Lung Cancer (IASLC). Prevention and early detection ... remains one of the hardest cancers to detect in ...
... ... , ... August 2, 2009 -- United Benefit Advisors, LLC (UBA), one of the nation,s leading ... health management. , , , , ,"The majority of employers clearly recognize the potential ...
... cancer patients who have progressed on a cetuximab-containing regimen ... reported today at the annual meeting of the International ... cetuximab (Erbitux) and erlotinib (Tarceva) inhibit the epidermal growth ... once a patient progresses on one EGFR inhibitor they ...
... FRANCISCO, August 1, 2009 The world,s top lung ... week in San Francisco, CA for the 13th World ... Association for the Study of Lung Cancer (IASLC). According ... WCLC, targeted therapies, as first-line treatment, have the potential ...
... FASTRACK ... Billing & Home HealthCare Agency Billing Software System. The FASTRACK Integrated IV, HME ... single common Microsoft SQL database that allows for the connection of remote sites via ... ...
... ... by Richard K. Riegelman, is hard-wired to the Association of American Colleges ... The book is an important part of a growing movement of several ... as a critical component of good citizenship and a prerequisite for taking ...
Cached Medicine News:Health News:Diagnostic tools and innovative therapies improve patient prognosis 2Health News:Diagnostic tools and innovative therapies improve patient prognosis 3Health News:Diagnostic tools and innovative therapies improve patient prognosis 4Health News:Diagnostic tools and innovative therapies improve patient prognosis 5Health News:Diagnostic tools and innovative therapies improve patient prognosis 6Health News:Employers Recognize Potential Impact of Employee Health Management on Future Plan Costs 2Health News:Employers Recognize Potential Impact of Employee Health Management on Future Plan Costs 3Health News:Fox Chase finds that lung cancer patients respond to erlotinib following cetuximab therapy 2Health News:Advanced targeted therapies effective as first-line treatment for lung cancer 2Health News:Advanced targeted therapies effective as first-line treatment for lung cancer 3Health News:Advanced targeted therapies effective as first-line treatment for lung cancer 4Health News:Advanced targeted therapies effective as first-line treatment for lung cancer 5Health News:Advanced targeted therapies effective as first-line treatment for lung cancer 6Health News:Advanced targeted therapies effective as first-line treatment for lung cancer 7Health News:Advanced targeted therapies effective as first-line treatment for lung cancer 8Health News:Fastrack Release First Integrated HME Billing, Infusion Pharmacy & Home Care Agency Software in a Microsoft Environment 2Health News:New Book by Leading Authority Responds to National Initiative to Bring Undergraduate Public Health Education to All American Colleges and Universities 2Health News:New Book by Leading Authority Responds to National Initiative to Bring Undergraduate Public Health Education to All American Colleges and Universities 3
(Date:9/29/2014)... , Sept. 29, 2014 Adaptive ... Next Generation Sequencing to profile the adaptive immune ... Scientific Advisory Board to provide strategic and clinical ... suite of assays in the diagnosis and monitoring ... focus of the SAB will be to support ...
(Date:9/29/2014)... BOSTON , Sept. 29, 2014  Arisaph ... on discovery and development of novel therapies for ... has been awarded a phase II Small Business ... I grant, both from the National Cancer Institute ... II award of $1,066,916 supports research and development ...
(Date:9/29/2014)... TEL-AVIV, Israel , Sept. 29, 2014 /PRNewswire/ ... ) ("Galmed"), a clinical-stage biopharmaceutical company focused on ... medication for the treatment of liver diseases and ... EndoPAT™ devices and accessories from Itamar Medical Ltd. ... company whose technology has been cleared by the ...
Breaking Medicine Technology:Adaptive Biotechnologies Announces the Formation of a Hematologic Malignancies Scientific Advisory Board 2Adaptive Biotechnologies Announces the Formation of a Hematologic Malignancies Scientific Advisory Board 3Arisaph Pharmaceuticals Awarded Supplemental Phase I And Phase II STTR Grants To Develop Oncology Drug Candidates 2Arisaph Pharmaceuticals Awarded Supplemental Phase I And Phase II STTR Grants To Develop Oncology Drug Candidates 3Arisaph Pharmaceuticals Awarded Supplemental Phase I And Phase II STTR Grants To Develop Oncology Drug Candidates 4Galmed Pharmaceuticals and Itamar Medical to Collaborate on Assessing Aramchol's Effect on Endothelial Function 2Galmed Pharmaceuticals and Itamar Medical to Collaborate on Assessing Aramchol's Effect on Endothelial Function 3
... Hospira, Inc. (NYSE: HSP ... announced positive results from a Phase I U.S. clinical ... renal (kidney) dysfunction who have anemia. Hospira,s trial met ... and distribution in the body, for Hospira,s EPO and ...
... 6, 2011 Omthera Pharmaceuticals, Inc., a privately-held emerging ... and Chief Executive Officer, will present at the Rodman ... 2011 at 2:25pm ET at the Waldorf Astoria Hotel ... Pharmaceuticals, Inc. Founded in 2008, Omthera ...
Cached Medicine Technology:Hospira Announces Positive Results From Phase I U.S. Clinical Trial of Biosimilar Erythropoietin in Renal Patients 2Hospira Announces Positive Results From Phase I U.S. Clinical Trial of Biosimilar Erythropoietin in Renal Patients 3
... FH system uses a ... infrastructure operating in ... communication of patient information. ... of up to 640 ...
Spacelabs offers an approach that allows your telemetry and step-down units to configure systems to meet their telemetry requirements. Our modular telemetry system data are integrated into the depart...
ISI Alumi-Hand is the safe, sterile, ready-to-use ,surgical hand immobilizer....
The Tele-Pro WEP-4200 Telemetry System is an 8-Patient Stand Alone System. Offering capabilities such as arrhythmia analysis, trends and full disclosure, the Tele-Pro is a system to help hospitals to...
Medicine Products: